Skip to main content
Moderna, Inc. (MUN:0QF)
Germany flag Germany · Delayed Price · Currency is EUR
41.44
-0.15 (-0.36%)
Last updated: Apr 28, 2026, 2:38 PM CET

Moderna Statistics

Total Valuation

Moderna has a market cap or net worth of EUR 16.46 billion. The enterprise value is 10.64 billion.

Market Cap 16.46B
Enterprise Value 10.64B

Important Dates

The next confirmed earnings date is Friday, May 1, 2026.

Earnings Date May 1, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 396.59M
Shares Outstanding n/a
Shares Change (YoY) +1.30%
Shares Change (QoQ) +0.51%
Owned by Insiders (%) 6.63%
Owned by Institutions (%) 80.55%
Float 369.96M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 9.94
PB Ratio 2.23
P/TBV Ratio 2.26
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a

Enterprise Valuation

EV / Earnings -4.43
EV / Sales 6.42
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -6.05

Financial Position

The company has a current ratio of 3.29, with a Debt / Equity ratio of 0.15.

Current Ratio 3.29
Quick Ratio 3.06
Debt / Equity 0.15
Debt / EBITDA n/a
Debt / FCF -0.63
Interest Coverage -307.40

Financial Efficiency

Return on equity (ROE) is -28.87% and return on invested capital (ROIC) is -63.28%.

Return on Equity (ROE) -28.87%
Return on Assets (ROA) -14.51%
Return on Invested Capital (ROIC) -63.28%
Return on Capital Employed (ROCE) -29.70%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 352,278
Profits Per Employee -511,382
Employee Count 4,700
Asset Turnover 0.15
Inventory Turnover 29.63

Taxes

In the past 12 months, Moderna has paid 45.99 million in taxes.

Income Tax 45.99M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +71.20% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +71.20%
50-Day Moving Average 33.90
200-Day Moving Average 40.93
Relative Strength Index (RSI) 59.63
Average Volume (20 Days) 141

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 7.08

Income Statement

In the last 12 months, Moderna had revenue of EUR 1.66 billion and -2.40 billion in losses. Loss per share was -6.18.

Revenue 1.66B
Gross Profit -1.75B
Operating Income -2.62B
Pretax Income -2.36B
Net Income -2.40B
EBITDA -2.44B
EBIT -2.62B
Loss Per Share -6.18

Balance Sheet

The company has 4.94 billion in cash and 1.11 billion in debt, giving a net cash position of 5.82 billion.

Cash & Cash Equivalents 4.94B
Total Debt 1.11B
Net Cash 5.82B
Net Cash Per Share n/a
Equity (Book Value) 7.37B
Book Value Per Share 18.70
Working Capital 3.88B

Cash Flow

In the last 12 months, operating cash flow was -1.60 billion and capital expenditures -163.53 million, giving a free cash flow of -1.76 billion.

Operating Cash Flow -1.60B
Capital Expenditures -163.53M
Depreciation & Amortization 183.55M
Net Borrowing 496.85M
Free Cash Flow -1.76B
FCF Per Share n/a

Margins

Gross margin is -105.76%, with operating and profit margins of -158.13% and -145.16%.

Gross Margin -105.76%
Operating Margin -158.13%
Pretax Margin -142.39%
Profit Margin -145.16%
EBITDA Margin -147.07%
EBIT Margin -158.13%
FCF Margin n/a

Dividends & Yields

Moderna does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.30%
Shareholder Yield -1.30%
Earnings Yield -14.60%
FCF Yield -10.68%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Moderna has an Altman Z-Score of 2.44 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.44
Piotroski F-Score 1